Simultaneous development of acute disseminated encephalomyelitis and guillain-barré syndrome associated with H1N1 09 influenza vaccination

Internal Medicine

Volumn 51, Issue 12, 2012, Pages 1595-1598

  Hoshino, Takao ^a   Uchiyama, Yumiko ^a   Ito, Eiichi ^a   Osawa, Shunsuke ^a   Ohashi, Takashi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute disseminated encephalomyelitis; Anti ganglioside antibody; GM2 ganglioside; Guillain barr ; Influenza vaccination; Syndrome

Indexed keywords

GADOLINIUM; GANGLIOSIDE ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INFLUENZA VACCINE; METHYLPREDNISOLONE;

2009 H1N1 INFLUENZA; ACUTE DISSEMINATED ENCEPHALOMYELITIS; ADULT; ARTICLE; BABINSKI REFLEX; BRAIN DAMAGE; CASE REPORT; CATHETERIZATION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GUILLAIN BARRE SYNDROME; HUMAN; INFLUENZA VACCINATION; MALE; MULTIPLE CYCLE TREATMENT; MUSCLE WEAKNESS; NERVE CONDUCTION; NERVE POTENTIAL; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; QUADRIPLEGIA; SENSORIMOTOR NEUROPATHY; SENSORY DYSFUNCTION; SPINAL CORD LESION; TENDON REFLEX; URINE RETENTION;

ADULT; AUTOANTIBODIES; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; G(M2) GANGLIOSIDE; GUILLAIN-BARRE SYNDROME; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; MAGNETIC RESONANCE IMAGING; MALE;

EID: 84862977212     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.7132     Document Type: Article

References (19)

1. Kesselring J, Miller DH, Robb SA, et al. Acute disseminated en-cephalomyelitis. MRI findings and the distinction from multiple sclerosis. Brain 113: 291-302, 1990.
2. van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol 7: 939-950, 2008.
3. Kaida K, Kusunoki S, Kamakura K, Motoyoshi K, Kanazawa I. Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a. Brain 123: 116-124, 2000.
4. Sakakibara R, Hattori T, Yasuda K, et al. Micturitional disturbance in acute disseminated encephalomyelitis (ADEM). J Auton Nerv Syst 60: 200-205, 1996.
5. Tenembaum S, Chitnis T, Ness J, et al. Acute disseminated en-cephalomyelitis. Neurology 68: S23-S36, 2007.
6. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet 366: 1653-1666, 2005.
7. Bromberg MB, Albers JW. Patterns of sensory nerve conduction abnormalities in demyelinating and axonal peripheral nerve disorders. Muscle Nerve 16: 262-266, 1993.
8. Nakayama T, Onoda K. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004. Vaccine 25: 570-576, 2007.
9. Liang XF, Li L, Liu DW, et al. Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China. N Engl J Med 364: 638-647, 2011.
10. Huber S, Kappos L, Fuhr P, Wetzel S, Steck AJ. Combined acute disseminated encephalomyelitis and acute motor axonal neuropathy after vaccination for hepatitis A and infection with Campylo-bacter jejuni. J Neurol 246: 1204-1206, 1999.
11. Sato N, Watanabe K, Ohta K, et al. Acute transverse myelitis and acute motor axonal neuropathy developed after vaccinations against seasonal and 2009 A/H1N1 influenza. Intern Med 50: 503-507, 2011.
12. Schwarz A, Futerman AH. The localization of gangliosides in neurons of the central nervous system: the use of anti-ganglioside antibodies. Biochim Biophys Acta 1286: 247-267, 1996.
13. Odaka M, Yuki N, Hirata K. Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry 70: 50-55, 2001.
14. Yuki N. Fisher syndrome and Bickerstaff brainstem encephalitis (Fisher-Bickerstaff syndrome). J Neuroimmunol 215: 1-9, 2009.
15. Kanter JL, Narayana S, Ho PP, et al. Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat Med 12: 138-143, 2006.
16. von Büdingen HC, Tanuma N, Villoslada P, et al. Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination. J Clin Immunol 21: 155-170, 2001.
17. Moore GR, Traugott U, Farooq M, et al. Experimental autoimmune encephalomyelitis. Augmentation of demyelination by different myelin lipids. Lab Invest 51: 416-424, 1984.
18. Menge T, Lalive PH, von Büdingen HC, et al. Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis. J Allergy Clin Immunol 116: 453-459, 2005.
19. Nishimura M, Saida T, Kuroki S, et al. Post-infectious encephalitis with anti-galactocerebroside antibody subsequent to Mycoplasma pneumoniae infection. J Neurol Sci 140: 91-95, 1996.